Showing results (141-150 of 255) with videos related to
Sort By:
Pageof 26
Blood|November 15, 2014
Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313Daniel O Persky, Thomas P Miller, Joseph M Unger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA StudiesJennifer L Kelly, Gilles Salles, Bryan Goldman, et al.Cancer Discovery|August 30, 2018
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent LymphomaMatthew J Frank, Patrick M Reagan, Nancy L Bartlett, et al.Blood|November 18, 2018
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016Xiaoyu Qu, Hongli Li, Rita M Braziel, et al.Leukemia Research|December 5, 2003
Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivoJonathan W Friedberg, Danielle A Dong, Sigui Li, et al.British Journal of Haematology|April 7, 2009
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomasJennifer R Brown, Jonathan W Friedberg, Yang Feng, et al.Blood|February 7, 2019
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative studyEric D Hsi, Hongli Li, Andrew B Nixon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Follicular lymphoma in the United States: first report of the national LymphoCare studyJonathan W Friedberg, Michael D Taylor, James R Cerhan, et al.Leukemia & Lymphoma|January 25, 2013
Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes databaseKarim E Abou-Nassar, Ann Vanderplas, Jonathan W Friedberg, et al.JACC. Cardiooncology|May 22, 2024
Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients With Hodgkin LymphomaJenica N Upshaw, Jason Nelson, Benjamin Sweigart, et al.Pageof 26